Adaptive Biotechnologies Corporation
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-34.9M | $-37.3M | $2.4M | $7.0M |
| FY2018 | $-32.3M | $-38.6M | $6.3M | $11.1M |
| FY2019 | $205.4M | $194.2M | $11.2M | $13.1M |
| FY2020 | $-149.7M | $-168.5M | $18.8M | $24.8M |
| FY2021 | $-192.7M | $-254.5M | $61.7M | $43.3M |
| FY2022 | $-183.9M | $-200.3M | $16.3M | $55.5M |
| FY2023 | $-156.3M | $-167.0M | $10.7M | $62.9M |
| FY2024 | $-95.2M | $-98.9M | $3.7M | $53.6M |
| FY2025 | $-46.0M | $-48.9M | $3.0M | $51.5M |